Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2003
05/22/2003WO2003041568A2 A three-dimensional matrix for producing living tissue equivalents
05/22/2003WO2003041560A2 Compounds and methods for treatment and diagnosis of chlamydial infection
05/22/2003WO2003041490A2 Novel isoamylases and associated methods and products
05/22/2003WO2003041483A2 Method to study and mechanisms of biofilm-related antibiotic resistance
05/22/2003WO2003027317A3 Use of active substances for the prophylaxis and/or treatment of diseases caused by cell growth disturbances and test system for discovery of said active substances
05/22/2003WO2003025203A3 Prediction of cancer by detection of atm mutations
05/22/2003WO2003025145A3 Nanomachine compositions and methods of use
05/22/2003WO2003018066A3 A murine genomic polynucleotide sequence encoding a g-protein coupled receptor and methods of use therefor
05/22/2003WO2003016908A3 Genes and gene products that confer susceptibility to vancomycin derivative antibiotics and methods and assays for identifying bifunctional glycopeptide antibiotics using same
05/22/2003WO2003016497A3 Molecules for disease detection and treatment
05/22/2003WO2003016464A3 Cancer specific oligosaccharide sequences and use thereof
05/22/2003WO2003012089A3 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
05/22/2003WO2003008562A3 Methods for detecting genes associated with bone properties, height, and/or body mass properties
05/22/2003WO2003004995A3 High-throughput stem cell assay of hematopoietic stem and progenitor cell proliferation
05/22/2003WO2003003904A3 Coactivators in the diagnosis and treatment of breast cancer
05/22/2003WO2003000112A3 Use of ribonuclease l in diagnosis of cancer
05/22/2003WO2002102987A3 Methods and compositions based on protein interactions with mastermind
05/22/2003WO2002101011A3 Reagents and methods for detection and characterization of protein-protein interactions
05/22/2003WO2002099436A3 Characterising polypeptides
05/22/2003WO2002094084A3 Bmpr1a involvement in juvenile polyposis
05/22/2003WO2002085298A3 Method for detecting breast cancer cells
05/22/2003WO2002084288A3 Individualization of therapy with antiarrhythmics
05/22/2003WO2002083839A3 P450 single nucleotide polymorphism biochip analysis
05/22/2003WO2002073212A3 Diagnostic screens for alzheimer's disease
05/22/2003WO2002070745A3 Polymorphisms in the zf9 gene linked to a predisposition for the development of inappropriate scarring of fibrosis
05/22/2003WO2002068685A3 Diagnostic test for the detection of chromosomal abnormalities in a fetus
05/22/2003WO2002068466A3 Hypoxia-regulated genes
05/22/2003WO2002066637A3 Method for collecting and using nuclear mrna
05/22/2003WO2002064830A3 Method for detecting dna polymerisation
05/22/2003WO2002059369A3 Compositions and methods for the treatment of diseases related to faulty cholesterol regulation
05/22/2003WO2002057487A3 Suppression of non-specific nucleic acid amplification
05/22/2003WO2002053780A3 5'-thio phosphate directed ligation of oligonucleotides and use in detection of single nucleotide polymorphisms
05/22/2003WO2002053740A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/22/2003WO2002051430A3 Methods of modulating toll-related receptor (trr) signaling
05/22/2003WO2002050283A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
05/22/2003WO2002046768A3 Proteins, genes and their use for diagnosis and treatment of chronic asthma
05/22/2003WO2002044427A9 Cell based triple readout assay systems for identifying compounds that effect transcription
05/22/2003WO2002044414A3 Purification of dna sequencing reactions using silica magnetic particles
05/22/2003WO2002040998A3 Kit and method for determining multiple analytes
05/22/2003WO2002040690A3 Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways
05/22/2003WO2002030561A3 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
05/22/2003WO2002018652A3 Method for detection of htr and htert telomerase-associated rna in plasma or serum
05/22/2003WO2002008466A9 A systematic approach to mechanism-of-response analyses
05/22/2003WO2001086003A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung
05/22/2003WO2001075177A3 Tumor markers in ovarian cancer
05/22/2003WO2001074298A3 Methods and compositions for regulating memory consolidation
05/22/2003WO2001070941A9 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
05/22/2003US20030097691 Obtaining nucleic acid sample from trees of pure species and/or hybrids thereof; obtaining restriction enzyme and/or standard PCR conditios correlating PCR-fingerprint or restriction pattern correlating PCR-fingerprint or restriction
05/22/2003US20030097687 Herbicide tolerant phenotype with an agronomic performance, genetic stability and adaptability to different genetic backgrounds equivalent to the non-transformed cotton line in the absence of weed pressure
05/22/2003US20030097683 For transformation of a host organism with a foreign RNA
05/22/2003US20030097671 Inhibition of betaarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
05/22/2003US20030097667 For therapy of Alzheimers disease, diagnosis
05/22/2003US20030097666 Novel human genes and gene expression products:II
05/22/2003US20030097059 Magnetic resonance spectroscopy to identify and classify microorganisms
05/22/2003US20030096987 Nucleic acid-bondable magnetic carrier and method for isolating nucleic acid using the same
05/22/2003US20030096983 Polynucleotide encoding a gene conferring resistance to bacillus thuringiensis toxins
05/22/2003US20030096982 Nucleotide sequences coding polypeptide for use in the treatment of immunological, reproductive and liver disorders
05/22/2003US20030096980 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
05/22/2003US20030096969 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096958 Polypeptide for use in the treatment of cancer and kidney disorders
05/22/2003US20030096953 Protein mixture for use in the detection of microbiocides
05/22/2003US20030096947 Placental organic anion transporter and gene thereof
05/22/2003US20030096784 Oligoribonucleotides and oligoribonucleosides that have subsequences of 2'-pentoribofuranosyl nucleosides that activate dsRNase (double stranded RNAase)
05/22/2003US20030096783 21132, a human G-protein coupled receptor family member and uses therefor
05/22/2003US20030096782 Expression profiling in the intact human heart
05/22/2003US20030096781 Interleukin-8 (IL-8); antisense nucleotide targeted to IL-8 for rapid treatment without the associated cumulative toxicity of conventional treatments
05/22/2003US20030096776 Inhibiting the division of a malignant mammalian cell and for modulating the effects of cellular aging
05/22/2003US20030096775 Treating multiple sclerosis, infection, or atherosclerosis
05/22/2003US20030096755 Suppression of inhibitors
05/22/2003US20030096744 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096742 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096733 Novel drug targets for arthritis
05/22/2003US20030096426 Forming microarray on surface of a substrate; provide vessel containing liquid in interior container, eject fluid onto surface of substrate, form array of sample
05/22/2003US20030096418 Preparation of solid support for use in the detection of particle in lipid layers; provide substrate, immerse in suspension, transfer to solid support, establish bulk aqueous phase above solid support, detect particle in solution
05/22/2003US20030096404 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
05/22/2003US20030096399 Enzymatic nucleotide sequence pool for use as tool in analysis of gene expression
05/22/2003US20030096396 Apparatus for use as tool in polymerase chain reaction
05/22/2003US20030096389 Composition for use as diagnostic tool in test kit
05/22/2003US20030096388 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
05/22/2003US20030096386 Nuclelotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorder
05/22/2003US20030096377 Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2
05/22/2003US20030096376 Generation of autoinducer-2; obtain S-adenosylhomocysteine, incubate with preferential protein, allow conversion of s-adenosylhomocysteine to autoinducer-2
05/22/2003US20030096359 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096357 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096356 G protein-coupled receptor protein for use in the diagnosis and treatment of alzheimer's disease
05/22/2003US20030096346 Nucleic acids, proteins, and antibodies
05/22/2003US20030096340 Nucleotide sequences coding polypeptide for use in the treatment, diagnosi and prevention of skin, kidney and cell proliferative disorders
05/22/2003US20030096333 Anthrax lethal factor is a MAPK kinase protease
05/22/2003US20030096332 Stabilized tetrazolium reagent compositions and methods for using the same
05/22/2003US20030096330 Genetically engineered cell for use as tool in controlling bacterial propagation and infection
05/22/2003US20030096325 Evaluating human sensitivity to antitumor agents; obtain blood sample, monitor blood glutathione concentration, amplified concentration indicates sensitivity to antitumor agents
05/22/2003US20030096324 Counting cells; obtain cells, deposit on slide, visualize cells, count cells
05/22/2003US20030096323 Detecting phosphodiesterase inhibitor; obtain cell, incubate with modulator, monitor expression of cyclic adenine and guanine monophosphates, compare to control, reduction in concentrations indicate inhibitor
05/22/2003US20030096322 System for cell-based screening
05/22/2003US20030096321 Method for the identification and/or the quantification of a target compound obtained from a biological sample upon chips
05/22/2003US20030096315 Device for detecting bacterial contamination and method of use
05/22/2003US20030096313 Novel serine-threonine kinase-4
05/22/2003US20030096312 Novel natrium-calcium exchanger protein
05/22/2003US20030096309 Screening system for identifying drug-drug interactions and methods of use thereof
1 ... 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 ... 3003